Effective 1 February 2022, DermLite, LLC (the “Company” or “we”) has unilaterally established the Minimum Advertised Price Policy (the “MAP Policy”) set forth below.
This MAP Policy is intended to discourage practices that may be detrimental to DermLite’s brand equity or may discourage investment in service, education, and support efforts provided by the resellers of our products. This MAP Policy is also intended to prevent resellers from taking unfair advantage of the service, education, and support efforts provided by other resellers.
This MAP Policy is being unilaterally adopted by the Company and we are not asking you to sign this agreement or be bound by its terms. We nevertheless thank you for reviewing this MAP Policy and look forward to doing business with you going forward.
Stay on top of the latest developments in dermoscopy and beyond